Dr. Fleming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
801 Harrison Ave
Elkins, WV 26241Phone+1 304-637-3640Fax+1 304-637-3644
Education & Training
University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1993
University of Louisville School of MedicineResidency, Internal Medicine, 1986 - 1989- University of Louisville School of MedicineClass of 1986
Certifications & Licensure
KY State Medical License 1987 - 2026
WV State Medical License 2008 - 2026
IN State Medical License 1996 - 2025
TN State Medical License 1993 - 1998
MD State Medical License 1990 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsToward Personalized Medicine of Lung Cancer Response to Nontargeted Therapy in Invasive Pulmonary Adenocarcinoma as a Function of Tumor Cell DifferentiationPaul H. Hartel, James V. Hartel, Julie C. Fanburg-Smith, R. Wayde Gilmore, Donald Fleming
International Journal of Surgical Pathology. 2013-05-01 - 211 citationsPhase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.Lajos Pusztai, Peter Wagner, Nuhad K. Ibrahim, Edgardo Rivera, Richard L. Theriault
Cancer. 2005-08-15 - 61 citationsA Phase II Study of DT Fusion Protein Denileukin Diftitox in Patients with Fludarabine-refractory Chronic Lymphocytic LeukemiaArthur E. Frankel, Donald R. Fleming, Philip D. Hall, Bayard L. Powell, Jennifer H Black
Clinical Cancer Research. 2003-09-01
Journal Articles
- Spontaneous Splenic Rupture in Polycythemia VeraMoore C, Fleming D, Rogers M, Clin Oncol and Research, 5/3/2018
- ,. Toward Personalized Medicine of Lung Cancer: Response to Nontargeted Therapy in Invasive Pulmonary Adenocarcinoma as a Function of Tumor Cell DifferentiationP H Hartel, J Hartel, J C Fanburg-Smith, W Gilmore, D R Fleming, S M Barnett, R Mudry, J E Parker, INT J SURG PATHOL, 5/1/2013
Professional Memberships
- Member
- Member
- West VIrginia Oncology SocietyVIce President 2014-2016
- West VIrginia Oncology SocietyPresident 2017-2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
